ALFA Finder| Revenue growth | 13% YoY in Insurance Revenue for FY26. |
|---|---|
| Margins | Combined ratio improved to 98.4% from 100.7% YoY. |
| Demand visibility | Strong, driven by 37% retail fresh GWP growth. |
| Management confidence | High, citing retail leadership and proprietary network expansion. |
Growth
Insurance Revenue grew 13% YoY to ₹17,999cr; PAT increased 16% to ₹911cr. Retail fresh GWP grew 37%.
Outlook
Guidance focuses on maintaining retail leadership, digital onboarding (96% current), and normalizing ROE toward 13.1% levels.
Risks
Rising expense ratios in Q4 (30.5%) and volatility in investment income due to marked-to-market losses.
Last quarter's promises, checked
Delivered
- Guided 1 lakh annual agent addition → delivered 1 lakh+ (= BEAT)
- Guided fresh retail growth on N basis → delivered 38% YoY (= BEAT)
- Guided improvement in combined ratio → delivered 98.8% from 101.1% (= BEAT)
Partly delivered
- Guided retail loss ratio improvement → delivered 64.8% (still above historical 65-66% range) (= PARTIAL)
Missed
- Guided positive PAT in Q4 → delivered ₹55cr loss due to MTM (= MISS)
Earnings Call filed with NSE, NSE: STARHEALTH. Summary written with AI assistance from the document.
Star Health and Allied Insurance Company Ltd: key numbers
- Share price
- ₹557.80
- Market cap
- ₹32,781 Cr
- Revenue (annual)
- ₹17,825 Cr
- Net profit (annual)
- ₹557.0 Cr
- P/E (TTM)
- 31.1×Sector 20.8×
- Promoter holding
- 58.00%-0.01% QoQ
- FII holding
- 15.86%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Health and Allied Insurance Company Ltd
All →Star Health and Allied Insurance Company Capital Structure Change
Star Health received IRDAI approval for HDFC Mutual Fund schemes to acquire equity up to 9.99% of paid-up capital, up from 4.49%. The approval extends the fund's existing stake and does not involve a stated rupee amount.
Star Health and Allied Insurance Company Results Update
Star Health reported Normalised PAT of ₹390 Crores in Q2 FY27, up 70% YoY. H1 FY27 PAT stood at ₹815 Crores, up 57% YoY.
Star Health and Allied Insurance Company Earnings Call Transcript: Key Takeaways
Star Health reported a significant structural turnaround with underwriting profitability for the fifth consecutive quarter.
- Call
- Guides 20% growth
Star Health and Allied Insurance Company Other Announcement
Star Health filed a NIL Reg 54 security cover certificate for unsecured NCDs. No secured debt is covered, so this is routine compliance.
Star Health and Allied Insurance Company Investor Presentation: Key Takeaways
H1 FY27 PAT ₹815 Cr (+57%); CISR improved to 97.9% from 100.3%; underwriting result ₹210 Cr vs loss ₹24 Cr. Retail fresh GWP +36%, driven by agency and D2C. Reported profit includes ₹229 Cr MTM gain.
Star Health and Allied Insurance Company Promoter Reclassification
Star Health's board approved reclassifying Sthitaprajna Advisors LLP from promoter group to public shareholder category. The move is subject to requisite regulatory approvals.